"Horizon 2020 - the Framework Programme for Research and Innovation".
Infoday 12. července 2012, Praha Judita Kinkorová
Obsah prezentace • 7. rámcový program 2007 – 2013 (7RP) • Kontext Horizontu 2020 • Hlavní rysy Horizontu 2020 • Priority Horizontu 2020 • Novinky Horizontu 2020 • Informační zdroje
2
7. Rámcový program pro VaV • 7. RP pro výzkum, technologický rozvoj a demonstrace (2007 – 2013) • rozpočet: 50,5 mld. € • největší unijní (komunitární) program • hlavní nástroj financování evropského výzkumu • podpora evropského výzkumu s cílem posílit konkurenceschopnost Evropy • 4 specifické programy – Spolupráce, Myšlenky, Lidé, Kapacity
3
1
FP versus HORIZON 2020
FP7
HORIZON 2020 •3 priorities
4 specific FP7 programmes
Billion €
Cooperation Cooperation
10 thematic programmes
€ 32.4
Ideas Ideas
basic research (ERC)
€ 7.5
People
Mobility (Marie Curie actions)
€ 4.7
Capacities
7 horizontal axes
€ 4.1
•Excellent Science •Competitive Industries •Better Society
4
FP7 versus Horizon 2020
Cooperation Priorities 1. 2. 3. 4.
5. 6. 7. 8. 9.
Health Food, agriculture and biotechnology Information and communication technologies Nanosciences, nanotechnologies, materials and new production technologies Energy Environment (including climate change) Transport (including aeronautics) Socio-economic sciences and the humanities Security and space
Better Society challenges • Health, demographic change and wellbeing; • Food security, sustainable agriculture, marine and maritime research, and the bio-economy; • Secure, clean and efficient energy; • Smart, green and integrated transport; • Inclusive, innovative and secure societies; • Climate action, resource efficiency and raw materials. 5
Novinky H 2020 • € 80.2 Billion marked in the Commission proposals for 20142020 EU budget • (June 2011) • • • •
Covering current funding for: • The 7th Framework Programme • The Competitiveness and Innovation Framework Programme (CIP) • The European Institute for Innovation and Technology (EIT)
• And strengthening complementarities with the Structural Funds
6
2
Societal challenges Proposed funding (million euro, 2014-20) • Health, demographic change and wellbeing
8 033
• Food security, sustainable agriculture, marine and maritime research & the bioeconomy
4 152
• Secure, clean and efficient energy*
5 782
• Smart, green and integrated transport
6 802
• Climate action, resource efficiency and raw materials
3 160
• Inclusive, innovative and secure societies
3 819 7
HEALTH, DEMOGRAPHIC CHANGE AND WELL-BEING Main Specific Challenges Considered • 1. Prevention • Better understanding and management of the relationship between environment, behaviour, nutrition, genetics and their contribution to health and disease. • Facilitating active and healthy ageing, and the prevention, delay and attenuation of disease and disability with tools and services including those supporting self care.
8
HEALTH, DEMOGRAPHIC CHANGE AND WELL-BEING Main Specific Challenges Considered • 2. Combating and curing disease • Better understanding the mechanisms of disease and redefining their taxonomies • Better understanding of the normal processes of human growth and development • Promoting conditions favouring drug discovery and development (through public private partnerships) • The development and validation of innovative therapies, medical technologies, and vaccines and diagnostics 9
3
HEALTH, DEMOGRAPHIC CHANGE AND WELL-BEING Main Specific Challenges Considered • 3. Increasing the sustainability and efficiency of the health and social care sector • Research in health systems, investment in capacity building, exchange of information between national systems, technology and quality assessments, investigation of health interventions, the socioeconomic impacts of health and disease. • Assistive and independent living solutions, ethics, service innovation, and societal uptake of innovation. • Enhancing preparedness for emerging epidemics and other emerging health threats. 10
HEALTH, DEMOGRAPHIC CHANGE AND WELL-BEING /1/ Overarching features considered: • Provision for the long-term study of well characterised, large populations; data collection and processing. • Development of and support for both biological and data infastructures (bio-banks, cohorts, animal models, etc.) and for other medical research facilities and infrastructures. • Support for the development of tools and technologies including –omics, high throughput research, systems biology and imaging, and for research using these.
11
HEALTH, DEMOGRAPHIC CHANGE AND WELL-BEING /2/ Overarching features considered: • Support for regulatory sciences (drug safety, clinical trials, cell & gene therapies, specialist manufacturing, etc.) • Support for converting knowledge into innovation, for the improvement of clinical practice and the development of marketable products and services.
12
4
HEALTH, DEMOGRAPHIC CHANGE AND WELL-BEING International co-operation: Major strategic international initiatives to be pursued, including: • Be a leader in large worldwide research consortia • EDCTP-2, Rare Diseases (International Rare Diseases Research Consortium - IRDiRC), International Human Microbiome Consortium – IHMC, International Initiative for Traumatic Brain Injury Research – InTBIR, Trans-Atlantic Task Force on antimicrobial resistance – TATFAR, etc., to improve availability of interventions
13
Další kroky Právě se děje: Vyjednávání Parlamentu a Rady o návrzích Komise Následně: Vyjednávání Parlamentu a Rady o rozpočtu EU 2014-2020 (včetně rozpočtu pro Horizont 2020) Polovina roku 2012: Poslední výzvy na základě Sedmého rámcového programu pro výzkum s cílem umožnit návaznost Horizontu 2020 Koncem roku 2013: Přijetí legislativy k programu Horizont 2020 Parlamentem a Radou 1/1/2014: Začíná Horizont 2020; zveřejnění prvních výzev 14
Informační zdroje Horizont 2020 http://cordis.europa.eu/fp7/
Cordis http://cordis.europa.eu/fp7/ http://cordis.europa.eu/partners-service/
Evropská komise http://ec.europa.eu/research
Research Participant Portal http://ec.europa.eu/research/participants/portal/page/home
Kontakty v ČR http://www.fp7.cz http://www.czelo.cz
15
5
Technologické centrum AV ČR Ve Struhách 27 160 00 Praha 6 Judita KINKOROVÁ
[email protected], 234 006 108
16
6
